日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

In Vivo Pharmacodynamic Evaluation of Omadacycline against Staphylococcus aureus in the Neutropenic Mouse Pneumonia Model

在嗜中性粒细胞减少小鼠肺炎模型中，对奥马环素抗金黄色葡萄球菌的体内药效学评价

期刊:Antimicrobial Agents and Chemotherapy
影响因子:4.5
doi:10.1128/AAC.02058-19
Lepak, Alexander J; Zhao, Miao; Marchillo, Karen; VanHecker, Jamie; Andes, David R
肺炎
中性粒细胞
粒细胞
细胞生物学
Mouse
发表日期：2020
文献求助 收藏

APX001 Pharmacokinetic/Pharmacodynamic Target Determination against Aspergillus fumigatus in an In Vivo Model of Invasive Pulmonary Aspergillosis

在侵袭性肺曲霉病体内模型中，确定 APX001 抗烟曲霉的药代动力学/药效学靶点

期刊:Antimicrobial Agents and Chemotherapy
影响因子:4.5
doi:10.1128/AAC.02372-18
Zhao, Miao; Lepak, Alexander J; Marchillo, Karen; Vanhecker, Jamie; Sanchez, Hiram; Ambrose, Paul G; Andes, David R
发表日期：2019
文献求助 收藏

In Vivo Pharmacodynamics of Omadacycline against Staphylococcus aureus in the Neutropenic Murine Thigh Infection Model

奥马环素在嗜中性粒细胞减少小鼠大腿感染模型中抗金黄色葡萄球菌的体内药效学研究

期刊:Antimicrobial Agents and Chemotherapy
影响因子:4.5
doi:10.1128/AAC.00624-19
Lepak, Alexander J; Zhao, Miao; Marchillo, Karen; VanHecker, Jamie; Andes, David R
炎症/感染
细胞生物学
中性粒细胞
粒细胞
发表日期：2019
文献求助 收藏

In Vivo Pharmacodynamic Target Determination for Delafloxacin against Klebsiella pneumoniae and Pseudomonas aeruginosa in the Neutropenic Murine Pneumonia Model

在嗜中性粒细胞减少的小鼠肺炎模型中，对德拉沙星抗肺炎克雷伯菌和铜绿假单胞菌的体内药效学靶点进行测定

期刊:Antimicrobial Agents and Chemotherapy
影响因子:4.5
doi:10.1128/AAC.01131-19
Zhao, Miao; Lepak, Alexander J; Marchillo, Karen; Andes, David R
肺炎
细胞生物学
中性粒细胞
粒细胞
发表日期：2019
文献求助 收藏

In Vivo Pharmacokinetics and Pharmacodynamics of APX001 against Candida spp. in a Neutropenic Disseminated Candidiasis Mouse Model

在嗜中性粒细胞减少性播散性念珠菌病小鼠模型中，APX001 抗念珠菌属的体内药代动力学和药效学研究

期刊:Antimicrobial Agents and Chemotherapy
影响因子:4.5
doi:10.1128/AAC.02542-17
Zhao, Miao; Lepak, Alexander J; VanScoy, Brian; Bader, Justin C; Marchillo, Karen; Vanhecker, Jamie; Ambrose, Paul G; Andes, David R
细胞生物学
Mouse
中性粒细胞
粒细胞
发表日期：2018
文献求助 收藏

Identification of the In Vivo Pharmacokinetics and Pharmacodynamic Driver of Iclaprim

伊克拉普林体内药代动力学和药效学驱动因素的鉴定

期刊:Antimicrobial Agents and Chemotherapy
影响因子:4.5
doi:10.1128/AAC.02550-17
Park, Jee Hyun; Craig, William; Marchillo, Karen; Huang, David B; Andes, David R
发表日期：2018
文献求助 收藏

In Vivo Pharmacodynamic Characterization of a Novel Odilorhabdin Antibiotic, NOSO-502, against Escherichia coli and Klebsiella pneumoniae in a Murine Thigh Infection Model

在小鼠大腿感染模型中，对新型奥迪洛拉布丁类抗生素NOSO-502进行体内药效学表征，以评估其对大肠杆菌和肺炎克雷伯菌的疗效。

期刊:Antimicrobial Agents and Chemotherapy
影响因子:4.5
doi:10.1128/AAC.01067-18
Zhao, Miao; Lepak, Alexander J; Marchillo, Karen; VanHecker, Jamie; Andes, David R
肺炎
炎症/感染
发表日期：2018
文献求助 收藏

In Vivo Pharmacodynamic Evaluation of Omadacycline (PTK 0796) against Streptococcus pneumoniae in the Murine Pneumonia Model

在小鼠肺炎模型中对奥马环素（PTK 0796）抗肺炎链球菌的体内药效学评价

期刊:Antimicrobial Agents and Chemotherapy
影响因子:4.5
doi:10.1128/AAC.02368-16
Lepak, Alexander J; Zhao, Miao; Marchillo, Karen; VanHecker, Jamie; Andes, David R
肺炎
发表日期：2017
文献求助 收藏

In Vivo Pharmacodynamic Target Assessment of Eravacycline against Escherichia coli in a Murine Thigh Infection Model

在小鼠大腿感染模型中对依拉环素抗大肠杆菌的体内药效学靶点进行评估

期刊:Antimicrobial Agents and Chemotherapy
影响因子:4.5
doi:10.1128/AAC.00250-17
Zhao, Miao; Lepak, Alexander J; Marchillo, Karen; VanHecker, Jamie; Andes, David R
炎症/感染
发表日期：2017
文献求助 收藏

Intraluminal Release of an Antifungal β-Peptide Enhances the Antifungal and Anti-Biofilm Activities of Multilayer-Coated Catheters in a Rat Model of Venous Catheter Infection

在静脉导管感染大鼠模型中，腔内释放抗真菌β肽可增强多层涂层导管的抗真菌和抗生物膜活性

期刊:ACS Biomaterials Science & Engineering
影响因子:5.5
doi:10.1021/acsbiomaterials.5b00427
Raman, Namrata; Marchillo, Karen; Lee, Myung-Ryul; Rodríguez López, Angélica de L; Andes, David R; Palecek, Sean P; Lynn, David M
炎症/感染
Rat
微生物学
发表日期：2016
文献求助 收藏